A pituitary tumor was the first sign of a rare gene syndrome
Original title: Acromegaly as the Initial Presentation of Multiple Endocrine Neoplasia Type 1: A Case Report.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This is a report about one patient, not a test of a new treatment.
The short version
One woman's brain gland tumor turned out to be the first sign of a rare inherited syndrome.
What was studied. This is a report about one patient. A 34-year-old woman had body changes from too much growth hormone, plus too much calcium in her blood.
What they found. Tests and an MRI scan showed a growth hormone tumor in her pituitary gland had come back. Imaging of her neck found a tumor on a parathyroid gland. A gene test found a rare harmful change in the MEN-1 gene. After a second surgery through the nose, the tumor was gone on scans and her hormone levels went back to normal.
What this means, and what it doesn't
What it could mean: High blood calcium along with a pituitary tumor can be a clue to MEN-1. Doctors may check for it even when no one else in the family has it. Finding it early can lead to surgery at the right time. It also starts regular checks for other tumors linked to the syndrome.
What it doesn't mean: This is a story about one patient, not a study in a group of people. It does not test a new drug or a new treatment. It is not proof that anything works better than current care. It is not a promise of a cure. People with this syndrome still need care from a team of doctors and checkups for life.
Source: PubMed, October 11, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.